Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Glycated haemoglobin (HbA1c) is monitored to guide treatment decisions in relation to glycaemic goals over time. Changes between two consecutive HbA1c tests result not only from deterioration or improvement in glycaemic control, but also from biovariability and measurement error. We model how this short-term variability impacts on HbA1c monitoring.

Original publication

DOI

10.1111/j.1464-5491.2011.03412.x

Type

Journal

Diabet Med

Publication Date

02/2012

Volume

29

Pages

266 - 271

Addresses

Department of Primary Health Care, University of Oxford and School of Primary Care Research, National Institute for Healthcare Research Somerville College, University of Oxford, UK. jason.oke@phc.ox.ac.uk.

Keywords

Aged, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 2, Evidence-Based Medicine, Female, Hemoglobin A, Glycosylated, Humans, Male, Patient Compliance, Regression Analysis, Treatment Outcome